We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Federal Off-Label Prosecution on the Rise, Industry Warns
Federal Off-Label Prosecution on the Rise, Industry Warns
August 24, 2006
The HHS Office of Inspector General (OIG) is leading the federal government’s effort to limit off-label drug promotion — a move that will hurt public health protection and may violate the First Amendment, industry attorneys say.